Alphabet Inc.
CIK
1652044
Location
Mountain View, CA
Portfolio Value
Mid
$4,015,570,577
Diversification
Moderately concentrated
Filing Date
Global Rank
#773
/ 8,603
▲ 235
· as of Mar 2026
Top Industry
Financial Data & Stock Exchanges
25.6%
3Y Alpha vs SPY
+18.3%
Period ended 3 months ago
Filed May 8, 2026 · 2mo
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+149.3%
SPY
+76.0%
Annualised alpha
+14.9%
Max drawdown
−39.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
26 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
25.6%
+1.6 pts
Top 5
84.0%
+11.6 pts
Top 10
94.0%
+3.0 pts
HHI
1,745
Moderately concentrated+329
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 34.3% | $1,376,202,240 |
| Financial Services | 26.7% | $1,071,117,949 |
| Industrials | 24.5% | $985,206,559 |
| Healthcare | 14.5% | $583,043,829 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PL | Planet Labs PBC | +3,306,252 | 35,248,893 | $985,206,559 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
3 positions
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | 189,122 | $126,711,740 | |
| DXCM | Dexcom Inc | 1,036,937 | $68,821,508 | |
| WGS | GeneDx Holdings Corp. | 22,711 | $2,953,792 | |
| EXAS | EXACT SCIENCES CORP | 23,205 | $2,356,699 | |
| FULC | Fulcrum Therapeutics, Inc. | 14,262 | $161,303 | |
| RGEN | Repligen Corp | 383 | $62,758 | |
| No positions match the current search. | ||||
26 positions ·
$4,015,570,577 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CME |
Cme Group Inc.
Financial Services
|
NEW | 3,484,020 | $1,029,005,307 | 25.63% | |
| PL |
Planet Labs PBC
Industrials
|
Added | 35,248,893 | $985,206,559 | 24.53% | |
| ASTS |
AST SpaceMobile, Inc.
Technology
|
Held | 8,943,486 | $741,146,684 | 18.46% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 3,292,525 | $320,198,056 | 7.97% | |
| ARM |
Arm Holdings PLC /Uk
Technology
|
Held | 1,960,784 | $296,627,403 | 7.39% | |
| FRSH |
Freshworks Inc.
Technology
|
Held | 16,206,643 | $130,139,343 | 3.24% | |
| PATH |
UiPath, Inc.
Technology
|
Held | 7,034,337 | $78,081,140 | 1.94% | |
| TEM |
Tempus AI, Inc.
Healthcare
|
Held | 1,551,102 | $70,140,832 | 1.75% | |
| PAYP |
PayPay Corp
Technology
|
NEW | 3,125,000 | $66,687,500 | 1.66% | |
| GTLB |
Gitlab Inc.
Technology
|
Held | 2,724,712 | $58,962,767 | 1.47% | |
| PRME |
Prime Medicine, Inc.
Healthcare
|
Held | 16,562,498 | $57,637,493 | 1.44% | |
| LIFE |
Ethos Technologies Inc.
Financial Services
|
NEW | 3,770,156 | $42,112,642 | 1.05% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Held | 1,388,583 | $41,449,202 | 1.03% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Held | 2,823,126 | $25,266,977 | 0.63% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 1,564,173 | $15,563,521 | 0.39% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 684,275 | $11,256,323 | 0.28% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 241,264 | $9,706,050 | 0.24% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
Held | 2,812,500 | $8,100,000 | 0.20% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Held | 321,604 | $7,663,823 | 0.19% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 293,256 | $5,882,715 | 0.15% | |
| OSCR |
Oscar Health, Inc.
Healthcare
|
Held | 481,988 | $5,528,402 | 0.14% | |
| FIG |
Figma, Inc.
Technology
|
Held | 215,582 | $4,557,403 | 0.11% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 889,979 | $2,082,550 | 0.05% | |
| HYPR |
Hyperfine, Inc.
Healthcare
|
Held | 898,720 | $970,617 | 0.02% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Held | 698,262 | $963,601 | 0.02% | |
| TNYA |
Tenaya Therapeutics, Inc.
Healthcare
|
Held | 915,705 | $633,667 | 0.02% |